The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cell cycle progression score to predict metastatic progression of clear cell renal cell carcinoma after resection.
Eric J. Askeland
No relevant relationships to disclose
Vincent A. Chehval
No relevant relationships to disclose
Ryan W. Askeland
No relevant relationships to disclose
Zaina Sangale
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Placede Gangnang Fosso
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Nafei Xu
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Saradha Rajamani
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Steven Stone
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
James A. Brown
No relevant relationships to disclose